Cabilatazan, Ricky C.
HRN: 25-51-26 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/17/2024
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
07/17/2024
07/24/2024
IV
1.5grams
Every 8hours
Empiric
Waiting Final Action
Indication: Empiric Type of Infection: Bone & JointSkin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes